Market Share of Prophylactic HIV Drugs Industry
The prophylactic HIV drug market is fragmented, with the presence of several players. Some of the prominent market participants are AbbVie, APOTEX INC., Auro Pharma Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Inc., F. Hoffmann-La Roche AG (Genentech Inc.), Johnson & Johnson Health Care Systems Inc., Gilead Sciences Inc., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline plc (ViiV Healthcare Group of Companies).
Prophylactic HIV Drugs Market Leaders
Merck & Co., Inc.
Cipla Inc
Bristol-Myers Squibb Company
Viatris Inc. (Mylan)
Johnson & Johnson
*Disclaimer: Major Players sorted in no particular order
